2025年3月18日 · Dupilumab (Dupixent) is used to treat eczema, asthma, chronic rhinosinusitis with nasal polyps, COPD with an eosinophilic phenotype, eosinophilic esophagitis, or prurigo nodularis. All these conditions have inflammation in common. Dupilumab is a subcutaneous injection that can be self-administered using a prefilled syringe or pen every 1 to 4 weeks …

2025年3月18日 · Applies to dupilumab: subcutaneous solution. Serious side effects of dupilumab. Along with its needed effects, dupilumab may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention. Check with your doctor immediately if any of the following side effects occur while taking ...

2025年3月11日 · Dupixent (dupilumab) has demonstrated significant efficacy in treating eosinophilic esophagitis (EoE) across various patient populations, from children to adults. Multiple clinical trials and real-world studies have consistently shown that Dupixent substantially reduces eosinophil counts, improves endoscopic appearance, and alleviates symptoms ...

Dupilumab se utiliza cuando otros tratamientos tópicos no fueron eficaces o dejaron de funcionar. Dupilumab también se utiliza junto con otros medicamentos para el tratamiento de mantenimiento del asma de moderada a severa en adultos y niños de al menos 6 años. Dupilumab no es un medicamento de rescate de acción rápida para los ataques de ...

2024年3月25日 · Detailed Dupilumab dosage information for adults and children. Includes dosages for Asthma, Sinusitis, Atopic Dermatitis and more; plus renal, liver and dialysis adjustments.

2024年12月10日 · Dupilumab did not alter immune response to tetanus antigen; immune responses to diphtheria and pertussis antigens not assessed. Vaccines, live. Not known if administration of live vaccines during dupilumab treatment will impact safety or effectiveness of these vaccines. Do not use in patients receiving dupilumab. Warfarin

2024年10月1日 · Dupixent (dupilumab) is an interleukin-4 receptor alpha antagonist used for the treatment of atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis, prurigo nodularis, and chronic obstructive pulmonary disease (COPD).

2024年3月25日 · Dupilumab Pregnancy and Breastfeeding Warnings. Brand names: Dupixent. Medically reviewed by Drugs.com. Last updated on Mar 25, 2024. Pregnancy Warnings; Breastfeeding Warnings; Dupilumab Pregnancy Warnings. This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus. AU TGA pregnancy category: B1

2024年10月10日 · Dupixent (dupilumab) has demonstrated significant efficacy in treating eosinophilic esophagitis (EoE) across various patient populations, from children to adults. Multiple clinical trials and real-world studies have consistently shown that Dupixent substantially reduces eosinophil counts, improves endoscopic appearance, and alleviates symptoms ...

Dupilumab (Ingredient) Drugbank ID: DB12159. The information below refers to products available in the United States that contain dupilumab. Products containing dupilumab dupilumab systemic. Brand name: Dupixent Drug class: interleukin inhibitors. Dupilumab systemic is used in the treatment of: Asthma; Asthma, Maintenance; Atopic Dermatitis